Microdenervation of the Spermatic Cord (MDSC)
Microdenervation of the spermatic cord (MDSC), also reported as microsurgical spermatic cord denervation (MSCD), is a testis-sparing neuroablative operation for chronic scrotal content pain in which the nerve-bearing tissues of the spermatic cord are divided under the operating microscope while the testicular arteries, a set of lymphatics and usually the vas deferens and its vessels are preserved. AUA 2025 states that clinicians may recommend MDSC for chronic scrotal content pain, especially after a favorable response to spermatic cord block (Statement 34; Conditional Recommendation, Grade C).[1][2] EAU recommends offering microsurgical denervation when testicular pain improves after a spermatic cord block (weak recommendation).[3]
For the definition, differential diagnosis, evaluation and nonsurgical ladder, see Chronic Scrotal Content Pain. Block technique is on Nerve Blocks.
Rationale
Levine and colleagues described microsurgical denervation in 1996 as a surgical alternative to orchiectomy for chronic orchialgia, and in 2001 reported it as the primary surgical treatment in men with temporary relief after cord block.[4][5] Heidenreich and colleagues reported a parallel European experience in 2002.[6]
The histologic basis is the distribution of injured nerves in the cord. In biopsies from 57 denervation procedures, Wallerian degeneration was found in 84% of orchialgia specimens and 20% of controls, concentrated in three sites: the cremasteric muscle layer (posterior portion most affected), the perivasal tissues and vasal sheath, and the posterior periarterial lipomatous tissue.[7] Immunohistochemical mapping found about 50% of cord nerves near the vas and 20% in the spermatic fascia, with sensory and sympathetic fibers co-localized in the same nerves.[8] Complete denervation divides all of this tissue; targeted denervation divides the three sites of the "trifecta nerve complex" and leaves the rest of the cord intact.[7][20]
Indications and Patient Selection
Candidates have chronic scrotal content pain of at least 3 months, pain localized to the testis or cord, a negative evaluation for structural, infectious and referred causes, and failure of conservative treatment.[1][18][21]
| Selection factor | Evidence |
|---|---|
| Positive spermatic cord block | Temporary relief predicted sustained improvement (p = 0.05) and was an independent predictor of response (p = 0.03) in 74 men (77 units)[9]. In placebo-controlled screening of 180 men, 37% had a positive response and were offered surgery[10]. A multicenter trial selected 50 men by response to a series of blocks that included a saline sham[11] |
| Idiopathic pain | The population in most series[5][18] |
| Post-vasectomy pain syndrome | 71% surgical success in 28 units, median follow-up 10 months[13]; a systematic review identified nine retrospective studies (213 patients) and supported MDSC for PVPS refractory to medical therapy[14] |
| Prior failed ipsilateral surgery | Complete relief in 50% of units with prior failed surgery, compared with 64% without[12] |
| Prior inguinal hernia repair | Complete resolution in 20 of 47 cords (43%) and improvement in 41 of 47 (87%) at a median 7 weeks[15] |
| Pelvic floor muscle spasm | Independently predicted failure (OR 3.95, p = 0.02); failure in 47% with spasm and 23% without[16] |
| Fertility wishes | Determine whether the vas is stripped and preserved or ligated[17] |
Perineal, bilateral scrotal, penile or suprapubic pain, or voiding or ejaculatory symptoms, point to the CP/CPPS phenotype rather than isolated CSCP.[2] Because pelvic floor muscle spasm independently predicted failure, a pelvic floor examination is part of preoperative selection.[16]
Preoperative Counseling
- Expected result. Complete relief in 49–80% of patients or units in most series (96% in one), with partial relief in a further 9–34%; outcome definitions and follow-up differ between series (see Outcomes).[5][6][11][18][21]
- Failure and recurrence. No change in pain in 12–17% of units in the larger series; in one series 5 of 103 men had recurrent pain more than 6 months after surgery.[16][18][21]
- Testis. The testis is preserved. Atrophy and hydrocele are uncommon but reported (see Complications).[18]
- Fertility. Ligation of the vas ends fertility on that side; stripping preserves the vas and gave the same pain outcome in a multicenter comparison.[17]
- Sensation. Excision of an ilioinguinal segment sacrifices that nerve's cutaneous territory; the robotic intra-abdominal approach was described as a way to preserve the ilioinguinal nerve.[19][22]
- Evidence quality. All outcome data are retrospective or uncontrolled case series; there is no sham-controlled surgical trial.[1][14]
Approaches
| Approach | Description | Reported results |
|---|---|---|
| Subinguinal microsurgical, complete | Incision at the external ring, cord delivered and skeletonized under the operating microscope, with micro-Doppler identification of the arteries; the standard open technique[18][19] | Complete relief 71% of 95 units[18] |
| Subinguinal microsurgical, targeted | Division limited to cremasteric fibers, perivasal tissue and posterior lipomatous tissue[20] | Resolution 69.8% targeted compared with 66.7% full; operative time 21 compared with 53 minutes[20] |
| Robot-assisted microsurgical, targeted | Robotic platform used for the microsurgical trifecta ligation[21] | Significant reduction in 83% of 860 cases; complete resolution 49%, median follow-up 24 months[21] |
| Robotic intra-abdominal (targeted robotic intra-abdominal denervation) | Division of genitofemoral and inferior hypogastric contributions above the internal ring, preserving the ilioinguinal nerve; described for failed cord denervation and post-orchiectomy pain[22] | Single-group experience; limited published data[22] |
Operative Technique
The steps below describe subinguinal complete denervation as reported in the Levine series and reviewed by Tatem and Kovac; individual surgeons vary the order.[5][18][19]
- Anesthesia and positioning. Supine, under general or regional anesthesia; a spermatic cord block can supplement either (see Nerve Blocks).
- Incision. Make a subinguinal incision over the external inguinal ring, as for microsurgical varicocelectomy.[19]
- Ilioinguinal nerve. Identify the nerve on the surface of the cord as it emerges from the ring. Excise a 2–3 cm segment and ligate the cut ends. With the inguinal approach, burying the proximal stump under the external ring has been described to reduce neuroma formation.[19]
- Cord delivery. Deliver the cord into the wound and bring it under the operating microscope.[19]
- Microscope and Doppler. Under the operating microscope, open the external and internal spermatic fascia. Identify the testicular artery or arteries with the micro-Doppler probe, together with their location, tubular morphology and visible pulsation, and systematically identify the veins, vas and lymphatics.[19]
- Lymphatics. Identify and preserve several lymphatic channels to reduce the risk of hydrocele.[8][19]
- Vas deferens. Preserve the vas and the deferential artery and strip the perivasal sheath and adventitia over a segment of the vas to remove the perivasal nerves. In men without fertility wishes, ligation and division of the vas is an alternative with the same reported pain outcome.[17][19]
- Division of the remaining cord. Ligate and divide the cremasteric fibers, the internal spermatic veins, the posterior lipomatous and periarterial tissue and all other tissue that does not contain the identified arteries, preserved lymphatics or vas. The genital branch of the genitofemoral nerve travels within the cord and is divided with this tissue.[7][18][19]
- Closure. At the end only the arteries, preserved lymphatics and the vas (if preserved) remain in continuity. Return the cord and close the wound.[18][19]
Targeted variant. Only the three trifecta sites are ligated: the cremasteric fibers, the perivasal sheath and the posterior lipomatous tissue. In a single-surgeon comparison, targeted and full denervation gave similar pain outcomes with a shorter operative time for the targeted operation.[7][20]
Pearls.
- Doppler identification of the arteries before any tissue is divided is intended to prevent inadvertent arterial ligation and testicular ischemia.[19]
- Lymphatic preservation is intended to reduce postoperative hydrocele.[8][19]
- After inguinal hernia repair, complete resolution was reported in 43% of cords at a median 7 weeks, lower than in idiopathic series.[15][18]
Postoperative Care
Postoperative care resembles that after microsurgical varicocelectomy: outpatient discharge, scrotal support, cold packs and short-course non-opioid analgesia. Pain is reassessed with the scale used before surgery. Medication tapering is part of the result, since Strom and Levine reported that successful denervation allowed patients to stop chronic medication.[18]
Outcomes
| Series | Design and population | Follow-up | Results |
|---|---|---|---|
| Levine and Matkov 2001[5] | 27 men, 33 units, all with temporary relief after cord block | Mean 20 months | Complete relief 76%, partial 9.1%, none 15% |
| Heidenreich 2002[6] | 35 men | Mean 31.5 months | 34 of 35 (96%) pain-free; no atrophy or hydrocele |
| Strom and Levine 2008[18] | 79 men, 95 units, positive cord block | Mean 20.3 months | Complete relief 71%, partial 17%, unchanged 12%; no patient worse |
| Benson 2013[9] | 74 men, 77 units | Mean 10 months | Mean pain 8 before block; mean 2 after MDSC (73% decrease) |
| Larsen 2013[12] | 68 men (70 units) treated 2006–2010; 31 units after prior failed ipsilateral surgery | Retrospective | Complete relief 64% without prior surgery and 50% after failed surgery |
| Oomen 2014[10] | 180 men screened with double-blind placebo-controlled blocks; surgery after positive blocks | Mean 42.8 months | 86.2% had at least 50% pain reduction; 51.7% pain-free |
| Marconi 2015[11] | Prospective multicenter open-label, 50 men | 6 months | Pain-free 80%, partial 12%, no change 8% |
| Calixte 2018[21] | Robot-assisted targeted, 860 cases with follow-up | Median 24 months | Significant reduction 83% (complete 49%, at least 50% reduction 34%); no change 17% |
| Tan 2018[13] | PVPS, 27 men, 28 units | Median 10 months | Surgical success 71% |
| Kavoussi 2019[20] | Targeted compared with full, single surgeon | Retrospective | Resolution 69.8% targeted and 66.7% full; failure 7.0% and 15.4% (not significant) |
| Murthy 2020[16] | 103 procedures | Retrospective | Success (complete resolution of bothersome pain) 73%; 77% excluding pelvic floor muscle spasm |
| El-Achkar 2025[17] | 85 men, multicenter, vas stripping (37) or ligation (48) | Median 12 months | Complete response 67.6% and 66.7% (p = 0.968); no testicular atrophy |
| Romanelli 2026[15] | 42 men, 47 cords, after inguinal hernia repair | Median 7 weeks | Complete resolution 43%, improvement 87% |
The series share limitations. They are retrospective or uncontrolled, mostly from high-volume microsurgeons, and define success differently (complete relief, at least 50% reduction, or resolution of bothersome pain). Most select patients by cord block, so the results apply to block responders.[1][9][14] The robotic series reported continued improvement on an objective pain instrument in 67% of patients at 6 months and 83% at 4 years.[21]
Complications
| Complication | Reported frequency and notes |
|---|---|
| Testicular atrophy | 2 of 95 units in the Strom and Levine series; none in the Heidenreich series or in either arm of the El-Achkar comparison[6][17][18] |
| Hydrocele | 2 of 95 units; none in the Heidenreich series[6][18] |
| Hematoma or hematocele | 1 hematocele in 95 units[18] |
| Wound infection | 1 superficial infection in 95 units[18] |
| Numbness | Follows from excision of an ilioinguinal segment; frequency not reported in the cited series. The intra-abdominal approach preserves the ilioinguinal nerve[19][22] |
| Persistent pain | No change in 12–17% of units in the larger series[18][21] |
| Recurrent pain | 5 of 103 men more than 6 months after surgery[16] |
| Loss of fertility on the operated side | After vas ligation, by design[17] |
After failed denervation, the evaluation is repeated for a second pain generator before further surgery. In the Cleveland Clinic series, two men whose denervation failed improved after genitofemoral nerve block.[16]
Comparison With Other Surgical Options
| Operation | Best indication | AUA 2025 position | Reported outcome | Testis and fertility |
|---|---|---|---|---|
| MDSC | Cord-localized idiopathic pain or PVPS with positive cord block | Statement 34, Conditional, Grade C[1] | Complete relief 49–96% across series[6][18][21] | Testis preserved; vas preserved unless ligated |
| Vasectomy reversal | PVPS | Statement 35, Expert Opinion[1] | Complete resolution 34%; mean pain 6.4 to 2.7[23] | Restores fertility |
| Epididymectomy | Pain and tenderness focal to the epididymis | Statement 39, Expert Opinion[1] | Cured or improved 72% of 225 men[24] | Ends fertility on that side |
| Inguinal triple neurectomy | Post-herniorrhaphy neuropathic pain | Not addressed; HerniaSurge supports selected use[30] | Described in 49 patients[25] | Cord not mobilized |
| Varicocelectomy | Painful varicocele concordant with symptoms | Not addressed | Dull pain resolves more often than dragging or sharp pain; microsurgical subinguinal repair favored[26] | Preserves testis |
| Inguinal orchiectomy with entire cord | Most invasive option after failed treatment | Statement 40, Expert Opinion; inguinal rather than scrotal[1] | Pain resolved 73% inguinal and 55% scrotal (Davis 1990)[27]; reviews cite 20–75% and 55–75%[22][28] | Testis lost |
Because orchiectomy fails in a substantial minority, reviews place cord denervation before extirpative surgery in idiopathic pain.[28][29]
See Also
- Chronic Scrotal Content Pain
- Chronic Pelvic Pain
- Myofascial Pelvic Pain
- Pelvic Floor Physical Therapy
- Nerve Blocks
- The Testicles & Scrotum
- Laparoscopic Pudendal Nerve Decompression
References
1. Lai HH, Pontari MA, Argoff CE, et al. "Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain." J Urol. 2025;214(2):138-146. doi:10.1097/JU.0000000000004566
2. American Urological Association. Diagnosis and Management of Male Chronic Pelvic Pain (Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Chronic Scrotal Content Pain): AUA Guideline (2025). Approved March 2025. Full 2025 guideline
3. Engeler D, Baranowski AP, Berghmans B, et al. EAU Guidelines on Chronic Pelvic Pain. European Association of Urology; limited update March 2026. Guideline. Scrotal pain syndrome sections.
4. Levine LA, Matkov TG, Lubenow TR. "Microsurgical denervation of the spermatic cord: a surgical alternative in the treatment of chronic orchialgia." J Urol. 1996;155(3):1005-1007. doi:10.1016/S0022-5347(01)66369-9
5. Levine LA, Matkov TG. "Microsurgical denervation of the spermatic cord as primary surgical treatment of chronic orchialgia." J Urol. 2001;165(6):1927-1929. doi:10.1016/S0022-5347(05)66244-1
6. Heidenreich A, Olbert P, Engelmann UH. "Management of chronic testalgia by microsurgical testicular denervation." Eur Urol. 2002;41(4):392-397. PMID 12074809
7. Parekattil SJ, Gudeloglu A, Brahmbhatt JV, et al. "Trifecta nerve complex: potential anatomical basis for microsurgical denervation of the spermatic cord for chronic orchialgia." J Urol. 2013;190(1):265-270. doi:10.1016/j.juro.2013.01.045
8. Oka S, Shiraishi K, Matsuyama H. "Microsurgical anatomy of the spermatic cord and spermatic fascia: distribution of lymphatics, and sensory and autonomic nerves." J Urol. 2016;195(6):1841-1847. doi:10.1016/j.juro.2015.11.041
9. Benson JS, Abern MR, Larsen S, Levine LA. "Does a positive response to spermatic cord block predict response to microdenervation of the spermatic cord for chronic scrotal content pain?" J Sex Med. 2013;10(3):876-882. doi:10.1111/j.1743-6109.2012.02937.x
10. Oomen RJ, Witjens AC, van Wijck AJ, Grobbee DE, Lock TM. "Prospective double-blind preoperative pain clinic screening before microsurgical denervation of the spermatic cord in patients with testicular pain syndrome." Pain. 2014;155(9):1720-1726. PMID 24861586
11. Marconi M, Palma C, Troncoso P, et al. "Microsurgical spermatic cord denervation as a treatment for chronic scrotal content pain: a multicenter open label trial." J Urol. 2015;194(5):1323-1327. doi:10.1016/j.juro.2015.05.081
12. Larsen SM, Benson JS, Levine LA. "Microdenervation of the spermatic cord for chronic scrotal content pain: single institution review analyzing success rate after prior attempts at surgical correction." J Urol. 2013;189(2):554-558. doi:10.1016/j.juro.2012.09.026
13. Tan WP, Tsambarlis PN, Levine LA. "Microdenervation of the spermatic cord for post-vasectomy pain syndrome." BJU Int. 2018;121(4):667-673. doi:10.1111/bju.14125
14. Tan WP, Levine LA. "Micro-denervation of the spermatic cord for post-vasectomy pain management." Sex Med Rev. 2018;6(2):328-334. doi:10.1016/j.sxmr.2017.06.002
15. Romanelli ME, Naelitz BD, Bole R, et al. "Microscopic spermatic cord denervation for chronic scrotal content pain following inguinal hernia repair: outcomes and predictors of success." Urology. 2026. PMID 41275976
16. Murthy PB, Parekh NV, Vij SC, Shoskes DA. "Microscopic spermatic cord denervation for chronic orchialgia/chronic scrotal content pain: operative outcomes and predictors of failure." Transl Androl Urol. 2020;9(5):1931-1936. PMID 33209657
17. El-Achkar A, et al. "Stripping versus ligation of vas deferens in microscopic denervation of spermatic cord in men with chronic orchialgia: a multicenter study." Andrology. 2025;13:268-274. doi:10.1111/andr.13650
18. Strom KH, Levine LA. "Microsurgical denervation of the spermatic cord for chronic orchialgia: long-term results from a single center." J Urol. 2008;180(3):949-953. doi:10.1016/j.juro.2008.05.018
19. Tatem A, Kovac JR. "Chronic scrotal pain and microsurgical spermatic cord denervation: tricks of the trade." Transl Androl Urol. 2017;6(Suppl 1):S30-S36. PMC5503921
20. Kavoussi PK. "Validation of targeted microsurgical spermatic cord denervation: comparison of outcomes to traditional complete microsurgical spermatic cord denervation." Asian J Androl. 2019;21(4):319-323. doi:10.4103/aja.aja_87_18
21. Calixte N, Tojuola B, Kartal I, et al. "Targeted robotic assisted microsurgical denervation of the spermatic cord for the treatment of chronic orchialgia or groin pain: a single center, large series review." J Urol. 2018;199(4):1015-1022. doi:10.1016/j.juro.2017.10.030
22. Parekattil SJ, Ergun O, Gudeloglu A. "Management of chronic orchialgia: challenges and solutions. The current standard of care." Res Rep Urol. 2020;12:199-210. doi:10.2147/RRU.S198785
23. Polackwich AS, Tadros NN, Ostrowski KA, et al. "Vasectomy reversal for postvasectomy pain syndrome: a study and literature review." Urology. 2015;86(2):269-272. PMID 26165616
24. Cole RM, Andino JJ, Daignault-Newton S, Quallich SA, Hadj-Moussa M. "Epididymectomy is an effective treatment for chronic epididymal pain." Urol Pract. 2024;11(2):409-415. doi:10.1097/UPJ.0000000000000515
25. Amid PK. "A 1-stage surgical treatment for postherniorrhaphy neuropathic pain: triple neurectomy and proximal end implantation without mobilization of the cord." Arch Surg. 2002;137(1):100-104. doi:10.1001/archsurg.137.1.100
26. Park JH, Pak K, Park NC, Park HJ. "How can we predict a successful outcome after varicocelectomy in painful varicocele patients? An updated meta-analysis." World J Mens Health. 2021;39:645-653. doi:10.5534/wjmh.190112
27. Davis BE, Noble MJ, Weigel JW, Foret JD, Mebust WK. "Analysis and management of chronic testicular pain." J Urol. 1990;143(5):936-939. doi:10.1016/s0022-5347(17)40143-1
28. Malaguti SA, Lund L. "Gold standard care of chronic scrotal pain." Res Rep Urol. 2021;13:283-288. doi:10.2147/RRU.S278803
29. Lowe G. "Extirpative surgery for chronic orchialgia: is there a role?" Transl Androl Urol. 2017;6(Suppl 1):S2-S5. PMID 28725610
30. HerniaSurge Group. "International guidelines for groin hernia management." Hernia. 2018;22(1):1-165. doi:10.1007/s10029-017-1668-x